Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification.
about
ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural OverviewCurcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse modelDevelopment of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1.Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2)Monoclonal antibodies for the treatment of osteoarthritis.Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis.A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active OligomersDevelopment of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivoInvestigational drugs for the treatment of osteoarthritis.Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis.Hemoglobin stimulates the expression of ADAMTS-5 and ADAMTS-9 by synovial cells: a possible cause of articular cartilage damage after intra-articular hemorrhage.Current status and future prospects for disease modification in osteoarthritis.Upper zone of growth plate and cartilage matrix associated protein protects cartilage during inflammatory arthritis.Recombinant TSR1 of ADAMTS5 Suppresses Melanoma Growth in Mice via an Anti-angiogenic Mechanism.
P2860
Q26747656-DBC0EC98-4714-4530-94D5-87E4D93ED58BQ27325703-A8555C11-0E67-48B2-885B-241CB32C43B6Q33641929-60ED30AA-5081-4A31-AA3B-E72AA23F193BQ33925651-EA6D8838-EF52-431E-ACB2-8F3D44F5E12BQ35754121-7FC03078-7F08-41FA-9BD1-CCA6086E49D4Q36113839-AA9DF015-7B51-4363-9091-52D93DD122FDQ36552031-B3C0A701-3369-412E-906E-3564EF4736A4Q36573930-4D168214-7CD4-4BC0-A5D5-55F17F32ADCFQ37086127-320FF54B-3F66-4867-8AE4-4EB6FEDF14FAQ38597565-87D078E9-1856-4C9D-9068-FC2A266E81DEQ42881603-3501D71E-668E-4CD0-8119-48C9E535F6C5Q46929706-480F414C-E354-40C5-937E-B277E0879776Q47570656-C8F7BE2B-3A35-48AA-9E8F-5B577AC333C1Q55112360-86B73684-BA2C-44AF-A322-38493F7EE15BQ55504021-91488C2D-E441-4600-AED7-A643B15F2F4D
P2860
Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Translational development of a ...... rthritis disease modification.
@ast
Translational development of a ...... rthritis disease modification.
@en
type
label
Translational development of a ...... rthritis disease modification.
@ast
Translational development of a ...... rthritis disease modification.
@en
prefLabel
Translational development of a ...... rthritis disease modification.
@ast
Translational development of a ...... rthritis disease modification.
@en
P2093
P2860
P50
P1476
Translational development of a ...... rthritis disease modification.
@en
P2093
A-M Malfait
L Elefante
P2860
P304
P356
10.1016/J.JOCA.2015.02.778
P577
2015-03-20T00:00:00Z